Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.9 |
mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.9 |
mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.9 |
mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0061 | 0.9 |